Sordilla, Rena Leunor .
HRN: 24-69-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
METRONIDAZOLE 500MG (TAB)
03/22/2024
04/01/2024
PO
500mg
Q8H
INTESTINAL AMOEBIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes